Ky.gov

Cabinet for Health and Family Services

KASPER - Kentucky All Schedule Prescription Electronic Reporting

​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​KASPER is a controlled substance prescription monitoring system designed to be a source of information to assist practitioners and pharmacists with providing medical and pharmaceutical patient care using controlled substance medications. KASPER also provides an investigative tool for law enforcement and regulatory agencies to assist with authorized reviews and investigations. KASPER is not intended to prevent patients from receiving needed controlled substance medications.

​

​Access to the KASPER system is carefully controlled through identity and credential checks and secure web access. Access to KASPER is available to the entities listed below.

  • Practitioners and pharmacists for medical or pharmaceutical treatment of their patient, and for reviewing data on controlled substances administered or dispensed to the birth mother of an infant being treated for neonatal abstinence syndrome or prenatal drug exposure.
  • Law enforcement officers for a bona fide drug-related investigation.
  • Commonwealth's attorneys and assistant commonwealth's attorneys, county attorneys and assistant county attorneys. 
  • Licensure boards for an investigation of a licensee.
  • A Medicaid program for utilization review on a recipient.
  • A grand jury by subpoena.
  • A judge or probation or parole officer administering a drug diversion or probation program.
  • A medical examiner engaged in a death investigation.

Pharmacies and dispensing practitioners are required to report to KASPER within one business day of administering or dispensing a controlled substance in KY as provided for under KRS 218A.202 ​and 902 KAR 55:110.

Pharmacies and other dispensers should report administered or dispensed controlled substance information through the KASPER Data Collection System. Reporting data to KASPER requires establishing and account via the Cabinet single sign-on system, Kentucky Online Gateway, then registering as an uploader in the KASPER Data Collection System. Please refer to KASPER Controlled Substance Reporting Guide  for information on how to register and report data to KASPER.

If you already have a KASPER account and no longer have access, please do not create a new account. Follow the instructions in the Links - Mandatory KASPER-KOG Account Instructions​.

Note: State government employees with @ky.gov email addresses should contact their supervisor/branch manager to add the KASPER app for enrollment.

To obtain a new KASPER account follow these steps:

Step1: Create a KOG account - KOG Help Desk (502)564-0104, ext.​ 2:

  1. Kentucky Online Gateway (KOG) account is the security portal to access all Cabinet for Health and Family Services protected systems (KASPER, kynect, Vitals, Death Registry, etc.). Go to the Kentucky Online Gateway website and create a citizen or business partner account. Remember your KOG user name (email) and password. Passwords are case sensitive and expire every 90 days. These credentials are required to access KASPER.

  2. After submitting your KOG information you will receive a KOG account activation email. You must activate your KOG account within four hours of receipt of the activation email. KOG-FAQ

Step 2: Create your KASPER account application:

  1. Sign in to your KOG account, click on All Apps and search (by the letter K) for Kentucky All Schedule Prescription Electronic Reporting and click the Enroll link to go to the Account Request Onboarding screen. Do not enter any information in the KASPER User Name/Password fields.

  2. Click on the Request a KASPER Account link at the bottom of the screen and follow the instructions to create your KASPER account application.

Step 3: Submit your KASPER account application:

During the account request process you may choose to either:

  1. Upload electronic copies of your required support documents and electronically sign your application (Paperless Application Process Video) or

  2. Mail the hard-copy application, signed Terms of Account Use and required support documents (follow instructions on application form).

​Your KASPER account registration is not complete until your application is processed by the Cabinet an​d you receive a Welcome to KASPER email. If you have not received this email within 14 days of submitting your account request, please contact the KASPER Business Office at (502) 564-7985 or via email.

Link to Request a New KOG and KASPER Account


For Kentucky Online Gateway (KOG) support contact the KOG Security Help Desk by phone (502) 564-0104, ext. 2 or email: KOG Help Desk.

For KASPER technical support contact the KASPER Help Desk by phone (502) 564-2703 or email: KASPER Help Desk 

​KASPER prescriber account holders can access their quarterly and annual KASPER Prescriber Report Cards. Please review the KASPER Prescriber Report Card User Guide for more information.

​If a KASPER report contains erroneous controlled substance prescription records, the practitioner or patient should contact the dispenser to verify the information reported. The dispenser can correct information reported in error by referring to the KASPER Record Correction guide. If the dispenser verifies that the information was reported accurately, the dispenser or practitioner should contact the Drug Enforcement and Professional Practices Branch at (502) 564-7985 to investigate the error.

Documentation

KASPER Trend Reports, Threshold Reports, Tips and Studies (select using the down arrow below)

For KASPER information, training and earlier Quarterly Trend Reports please contact KASPER Program Administrator here​​​​​.

All Documents
EditTypeDownloadTitlePublished DateKASPER CategoryModifiedChecked Out To
0pdfControlled Substance Prescribing Guideline for APRNsControlled Substance Prescribing Guideline for APRNs  2/18/2021 12:54 PM 
0pdfDEA Reverse Distributor List DEA Reverse Distributor List 7/27/2022 7/28/2022 9:34 AM 
0pdf   10/9/2020 1:47 PM 
0pdf   2/11/2021 1:53 PM 
0pdfEPCS Temporary Exemption Request Form - EditableEPCS Temporary Exemption Request Form - Editable10/7/2020 10/7/2020 9:34 AM 
0pdfGeographic Patterns in Neonatal Abstinence Syndrome and Prescription Opioids in KentuckyGeographic Patterns in Neonatal Abstinence Syndrome and Prescription Opioids in Kentucky Studies/Surveys4/24/2018 2:44 PM 
0pdf   10/9/2020 1:39 PM 
0pdfKentucky Revised Statutes and Administrative Regs Pertaining to an Electronic System for Monitoring Controlled SubstancesKentucky Revised Statutes and Administrative Regs Pertaining to an Electronic System for Monitoring Controlled Substances11/21/2022Tips11/21/2022 8:41 AM 
0pdfKASPER Trend Report Q1 2023KASPER Trend Report Q1 20238/30/2023Trend Reports8/30/2023 4:03 PM 
0pdfKASPER Trend Report Q2 2023KASPER Trend Report Q2 20238/30/2023Trend Reports8/30/2023 4:03 PM 
0pdfKASPER Trend Report Q3 2023KASPER Trend Report Q3 202312/11/2023Trend Reports12/11/2023 4:17 PM 
0pdfKASPER Trend Report Q4 2023KASPER Trend Report Q4 20231/17/2024Trend Reports4/16/2024 4:27 PM 
0pdfKASPER Annual Threshold Report 2016KASPER Annual Threshold Report 201612/1/2015Threshold Reports10/9/2020 1:39 PM 
0pdfKASPER Annual Threshold Report 2016KASPER Annual Threshold Report 201612/1/2016Threshold Reports4/24/2018 2:40 PM 
0pdfKASPER Controlled Substance Reporting GuideKASPER Controlled Substance Reporting Guide5/31/2022 5/31/2022 12:21 PM 
0pdfA KASPER Guide for Kentucky CoronersA KASPER Guide for Kentucky Coroners9/26/2019Tips9/26/2019 12:50 PM 
0pdfKASPER-KOG Frequently Asked QuestionsKASPER-KOG Frequently Asked Questions4/18/2019 5/16/2019 9:05 AM 
0pdfKASPER - KOG Integration User GuideKASPER - KOG Integration User Guide8/15/2019 2/25/2023 11:22 AM 
0pdfKASPER Prescriber Report Card User GuideKASPER Prescriber Report Card User Guide3/26/2020 4/14/2020 1:48 PM 
0pdfKASPER Quarterly Threshold Analysis Report 1Q 2016KASPER Quarterly Threshold Analysis Report 1Q 20161/1/2016Threshold Reports4/24/2018 2:40 PM 
0pdfKASPER Quarterly Threshold Analysis Report 1Q 2017KASPER Quarterly Threshold Analysis Report 1Q 20171/1/2017Threshold Reports4/24/2018 2:40 PM 
0pdfKASPER Quarterly Threshold Analysis Report 1Q 2018KASPER Quarterly Threshold Analysis Report 1Q 20181/3/2019Threshold Reports10/9/2020 1:39 PM 
0pdfKASPER Quarterly Threshold Analysis Report 2Q 2016KASPER Quarterly Threshold Analysis Report 2Q 20162/1/2016Threshold Reports4/24/2018 2:40 PM 
0pdfKASPER Quarterly Threshold Analysis Report 2Q 2017KASPER Quarterly Threshold Analysis Report 2Q 20172/1/2017Threshold Reports4/24/2018 2:40 PM 
0pdfKASPER Quarterly Threshold Analysis Report 2Q 2018KASPER Quarterly Threshold Analysis Report 2Q 20181/4/2019Threshold Reports10/9/2020 1:39 PM 
0pdfKASPER Quarterly Threshold Analysis Report 3Q 2016KASPER Quarterly Threshold Analysis Report 3Q 20163/1/2016Threshold Reports4/24/2018 2:40 PM 
0pdfKASPER Quarterly Threshold Analysis Report 3Q 2017KASPER Quarterly Threshold Analysis Report 3Q 20173/1/2017Threshold Reports4/24/2018 2:40 PM 
0pdfKASPER Quarterly Threshold Analysis Report 4Q 2017KASPER Quarterly Threshold Analysis Report 4Q 20174/1/2017Threshold Reports4/24/2018 2:40 PM 
0pdfKASPER Trend Report Q1 2017KASPER Trend Report Q1 20171/1/2017Trend Reports4/24/2018 2:40 PM 
0pdfKASPER Trend Report Q1 2018KASPER Trend Report Q1 20188/7/2018Trend Reports10/9/2020 1:39 PM 
0pdfKASPER Trend Report Q1 2019KASPER Trend Report Q1 20195/22/2019Trend Reports10/9/2020 1:39 PM 
0pdfKASPER Trend Report Q1 2020KASPER Trend Report Q1 20206/17/2020Trend Reports10/9/2020 1:39 PM 
0pdfKASPER Trend Report Q1 2021KASPER Trend Report Q1 20215/24/2021Trend Reports5/24/2021 4:31 PM 
0pdfKASPER Trend Report Q1 2022KASPER Trend Report Q1 20225/31/2022Trend Reports1/31/2023 1:59 PM 
0pdfKASPER Trend Report Q2 2017KASPER Trend Report Q2 20172/1/2017Trend Reports4/24/2018 2:40 PM 
0pdfKASPER Trend Report Q2 2018KASPER Trend Report Q2 20188/8/2018Trend Reports10/9/2020 1:39 PM 
0pdfKASPER Trend Report Q2 2019KASPER Trend Report Q2 20198/20/2019Trend Reports8/20/2019 12:33 PM 
0pdfKASPER Trend Report Q2 2020KASPER Trend Report Q2 20208/17/2020Trend Reports10/9/2020 1:40 PM 
0pdfKASPER Trend Report Q2 2021KASPER Trend Report Q2 20217/28/2021Trend Reports7/28/2021 2:35 PM 
0pdfKASPER Trend Report Q2 2022KASPER Trend Report Q2 20227/27/2022Trend Reports1/31/2023 2:12 PM 
0pdfKASPER Trend Report Q3 2017KASPER Trend Report Q3 20173/1/2017Trend Reports4/24/2018 2:40 PM 
0pdfKASPER Trend Report Q3 2018KASPER Trend Report Q3 201811/6/2018Trend Reports10/9/2020 1:39 PM 
0pdfKASPER Trend Report Q3 2019KASPER Trend Report Q3 201911/19/2019Trend Reports11/19/2019 10:00 AM 
0pdfKASPER Trend Report Q3 2020KASPER Trend Report Q3 202012/17/2020Trend Reports12/17/2020 10:25 AM 
0pdfKASPER Trend Report Q3 2021KASPER Trend Report Q3 202112/23/2021Trend Reports5/31/2022 11:22 AM 
0pdfKASPER Trend Report Q4 2017KASPER Trend Report Q4 20174/1/2017Trend Reports4/24/2018 2:40 PM 
0pdfKASPER Trend Report Q4 2018KASPER Trend Report Q4 20182/19/2019Trend Reports10/9/2020 1:39 PM 
0pdfKASPER Trend Report Q4 2019KASPER Trend Report Q4 20192/20/2020Trend Reports2/20/2020 9:53 AM 
0pdfKASPER Trend Report Q4 2020KASPER Trend Report Q4 20203/17/2021Trend Reports3/17/2021 4:21 PM 
0pdfKASPER Query Guidelines at a GlanceKASPER Query Guidelines at a Glance8/1/2022Tips11/1/2022 3:58 PM 
0pdfKASPER Real Time Data Collection Study Executive Summary 2006-2011KASPER Real Time Data Collection Study Executive Summary 2006-2011 Studies/Surveys4/24/2018 2:43 PM 
0pdfRequest for KASPER Patient ReportRequest for KASPER Patient Report7/10/2020 7/10/2020 4:05 PM 
0pdf2010 KASPER Satisfaction Survey Executive Summary2010 KASPER Satisfaction Survey Executive Summary Studies/Surveys10/9/2020 1:39 PM 
0pdfControlled Substance Prescribing Part 1Controlled Substance Prescribing Part 1 Tips7/27/2018 2:48 PM 
0pdfControlled Substance Prescribing Part 2Controlled Substance Prescribing Part 2 Tips4/24/2018 2:40 PM 
0pdfInterpreting KASPER ReportsInterpreting KASPER Reports2/23/2023Tips2/25/2023 12:13 PM 
0pdfKASPER Record CorrectionKASPER Record Correction Tips9/8/2021 2:22 PM 
0pdfMorphine Equivalent Dose and Naloxone InformationMorphine Equivalent Dose and Naloxone Information Tips12/5/2018 12:34 PM 
0pdfObtaining Your KASPER Account Verification CertificateObtaining Your KASPER Account Verification Certificate8/11/2020Tips2/25/2023 12:09 PM 
0pdfPrescribing Buprenorphine for Office Based Opioid TreatmentPrescribing Buprenorphine for Office Based Opioid Treatment Tips4/24/2018 2:40 PM 
0pdfReducing Manual Process ReportsReducing Manual Process Reports Tips4/24/2018 2:40 PM 
0pdfIdentifying Patients Who May Have Experienced a Drug OverdoseIdentifying Patients Who May Have Experienced a Drug Overdose11/7/2019Tips11/1/2022 4:15 PM 
0pdfReverse KASPERReverse KASPER Tips2/25/2023 12:13 PM 
0pdfWhen Physicians Must Report to KASPERWhen Physicians Must Report to KASPER Tips3/26/2019 12:42 PM 
0pdfWhen to Request a KASPER ReportWhen to Request a KASPER Report8/1/2022Tips11/1/2022 4:17 PM 
0pdfKASPER Web Browser Security GuidanceKASPER Web Browser Security Guidance7/28/2020 7/28/2020 9:19 AM 
0pdfKY Controlled Substance Regulations (KAR Title 902 Chapter 55)KY Controlled Substance Regulations (KAR Title 902 Chapter 55)7/26/2021 7/28/2022 9:31 AM 
0pdf   1/10/2018 1:52 PM 
0pdfHouse Bill 1 Evaluation Study Report AppendicesHouse Bill 1 Evaluation Study Report Appendices Studies/Surveys4/24/2018 2:43 PM 
0pdfHouse Bill 1 Evaluation Study Executive SummaryHouse Bill 1 Evaluation Study Executive Summary Studies/Surveys4/24/2018 2:42 PM 
0pdfHouse Bill 1 Evaluation Study ReportHouse Bill 1 Evaluation Study Report Studies/Surveys4/24/2018 2:43 PM 
0pdfKY Controlled Substance Handbook (KRS 218A)KY Controlled Substance Handbook (KRS 218A)7/27/2022 7/28/2022 9:36 AM 
0pdfKentucky Scheduled Drug ListKentucky Scheduled Drug List7/26/2022 7/28/2022 9:41 AM 
0pdf   10/9/2020 1:39 PM 
0pdfInformation on the Scheduling of TianeptineInformation on the Scheduling of Tianeptine4/17/2023 4/17/2023 7:50 AM 
0pdfKentucky Prescriptive Authority - A Guide for PharmacistsKentucky Prescriptive Authority - A Guide for Pharmacists7/23/2020 2/18/2021 1:02 PM 
0pdfKentucky Security Prescription Blank RequirementsKentucky Security Prescription Blank Requirements  8/1/2019 2:16 PM 
0pdfMandatory EPCS Information for Kentucky Mandatory EPCS Information for Kentucky 7/24/2020 2/1/2021 9:54 AM 
0pdf   1/10/2018 1:52 PM 
0pdfNational Governors Assoc PDMP ToolkitNational Governors Assoc PDMP Toolkit9/10/2020 10/9/2020 1:40 PM 
0pptxKASPER Trend Report Q1 2024KASPER Trend Report Q1 20244/17/2024Trend Reports4/16/2024 4:28 PM 

For technical issues or support for the use of the KASPER system, contact the KASPER ​​Help Desk by:

​Phone​: (502) 564-2703
Email: KASPER Help Desk ​

EPCS Mandate

KRS 218A.182 took effect Jan. 1, 2021 and mandates electronic prescribing of controlled substances (EPCS) in Kentucky. A practitioner who is unable to comply with the EPCS mandate may request a waiver by submitting an EPCS Temporary Exemption Request Form /EPCS Form (pdf)   to CHFS. Although initial waivers were due by Nov. 1, 2020, the Cabinet still is accepting Temporary Exemption Forms. Please send forms by mail to Drug Enforcement and Professional Practices Branch at the address shown on the form or by email to KASPER.​

Integration

KASPER offers integration with account holders' electronic health record or pharmacy management systems. Integration provides fast, reliable and simplified access to KASPER information within the practitioners' or pharmacists' existing workflow. For additional information about the integration process and requirements, please email the KASPER Integration Team.
​
​
​

Additional Information

Contact Information

187

Related Agencies